Cyr61/CNN1 has been described as potential serum marker for CRC (Song et al., 2017), whereas Cyr61 expression in the tumor tissue indicates poor prognosis in colon cancer patients being statistically associated with greater mortality (Jeong et al., 2014). The gene discussed is CCN1; the disease is neoplasm.